The invention provides compositions and methods for intravenous administration of 2-bromo-1-(33-dinitroazetidin-1-yl)ethanone (ABDNAZ) including formulations containing autologous whole blood and ABDNAZ that can be rapidly administered to a patient by intravenous infusion without any significant pain at the site of infusion.